Treatment of patients with recently exacerbated schizophrenia with paliperidone palmitate: a pilot study of efficacy and tolerability (2020)
- Authors:
- USP affiliated authors: GATTAZ, WAGNER FARID - FM ; ELKIS, HELIO - FM
- Unidade: FM
- DOI: 10.2147/NDT.S233537
- Subjects: ESQUIZOFRENIA; TOLERÂNCIA; PACIENTES; COMPOSTOS HETEROCÍCLICOS; PACIENTES
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Neuropsychiatric disease and treatment
- ISSN: 1178-2021
- Volume/Número/Paginação/Ano: v. 16, p. 2063-2072, 2020
- Status:
- Artigo publicado em periódico de acesso aberto (Gold Open Access)
- Versão do Documento:
- Versão publicada (Published version)
- Acessar versão aberta:
-
ABNT
GATTAZ, Wagner Farid et al. Treatment of patients with recently exacerbated schizophrenia with paliperidone palmitate: a pilot study of efficacy and tolerability. Neuropsychiatric disease and treatment, v. 16, p. 2063-2072, 2020Tradução . . Disponível em: https://doi.org/10.2147/NDT.S233537. Acesso em: 01 abr. 2026. -
APA
Gattaz, W. F., Saracco-Alvarez, R., Daltio, C. S., Bilt, M. T. V. de, Ortegon, J. J., Villasenor-Bayardo, S. J., et al. (2020). Treatment of patients with recently exacerbated schizophrenia with paliperidone palmitate: a pilot study of efficacy and tolerability. Neuropsychiatric disease and treatment, 16, 2063-2072. doi:10.2147/NDT.S233537 -
NLM
Gattaz WF, Saracco-Alvarez R, Daltio CS, Bilt MTV de, Ortegon JJ, Villasenor-Bayardo SJ, Louza M, Elkis H, Soares B, Jaramillo PC. Treatment of patients with recently exacerbated schizophrenia with paliperidone palmitate: a pilot study of efficacy and tolerability [Internet]. Neuropsychiatric disease and treatment. 2020 ; 16 2063-2072.[citado 2026 abr. 01 ] Available from: https://doi.org/10.2147/NDT.S233537 -
Vancouver
Gattaz WF, Saracco-Alvarez R, Daltio CS, Bilt MTV de, Ortegon JJ, Villasenor-Bayardo SJ, Louza M, Elkis H, Soares B, Jaramillo PC. Treatment of patients with recently exacerbated schizophrenia with paliperidone palmitate: a pilot study of efficacy and tolerability [Internet]. Neuropsychiatric disease and treatment. 2020 ; 16 2063-2072.[citado 2026 abr. 01 ] Available from: https://doi.org/10.2147/NDT.S233537 - Algumas recomendações para estudos com placebo
- Ventricular enlargement as a predictor of therapeutic response in schizophrenia: a structural MRI study
- Niacin test in schizophrenia and in major depression
- Switching from oral risperidone to flexibly dosed oral paliperidone extended-release: core symptoms, satisfaction, and quality of life in patients with stable but symptomatic schizophrenia: the RISPALI study
- Leonhard´s classification of Schizophrenias and MRI brain abnormalities: preliminary results
- Decreased S100-beta protein in schizophrenia: preliminary evidence
- Conjugated estrogens as adjuvant therapy in the treatment of acute schizophrenia:: a double-blind study
- Esquizofrenia e gênero
- A double blind placebo controlled study of conjugated estrogens added to haloperidol in patients with schizophrenia
- Aripiprazole for Patients with Schizophrenia and Schizoaffective Disorder: An Open-Label, Randomized, Study Versus Haloperidol
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
